Skip to main content
. 2018 Jun 16;23(6):1465. doi: 10.3390/molecules23061465

Figure 2.

Figure 2

Tumor-to-kidney ratios of mice after injection of [177Lu]folate (5 MBq, 1 nmol). (a) Tumor-to-kidney ratios of KB tumor-bearing mice 4 h after injection of [177Lu]cm13 without pre-injected PMX (blue) or with pre-injected PMX (yellow). (b) Tumor-to-kidney ratios of KB tumor-bearing mice 24 h after injection of [177Lu]cm13 without pre-injection of PMX (blue) or with pre-injection of PMX 1 h before the radiofolate (yellow) or 1 h before and 3 h (green) or 7 h (red) after injection of the radiofolate. (c) Tumor-to-kidney ratios of IGROV-1 tumor-bearing mice 4 h after injection of [177Lu]cm13 without pre-injected PMX (blue) or with pre-injected PMX (yellow). (d) Tumor-to-kidney ratios of IGROV-1 tumor-bearing mice 24 h after injection of [177Lu]cm13 without pre-injection of PMX (blue) or with pre-injection of PMX 1 h before the radiofolate (yellow) or 1 h before and 3 h (green) or 7 h (red) after injection of the radiofolate. Statistically significant values are indicated with asterisks (* p ≤ 0.05).